NCT01314885 - Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

PF-03715455

20mg, Inhaled, single dose

DRUG

PH-797804

30mg, Oral, single dose

DRUG

Placebo for PF-03715455

Single dose, inhaled, Placebo for PF-03715455

DRUG

Placebo for PH-797804

Single Dose, Oral, Placebo for PH-797804

Trial Locations (2)

Pfizer Investigational Site, London

Pfizer Investigational Site, Manchester